Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease
Journal of Alzheimer’s Disease · 2024
DOI: 10.1177/13872877241289053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Hattapark Dejakaisaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, School of Translational Medicine, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Ceftriaxone, Alzheimer Disease, Mice, Transgenic, Seizures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Individuals with Alzheimer's disease (AD) have a heightened risk of epilepsy. However, the underlying mechanisms are not well-understood.
Objective
We aimed to elucidate the role of the glutamate-glutamine cycle in this mechanism and test the effect of ceftriaxone, a glutamate transporter-1 (GLT-1) enhancer, on seizure susceptibility in the Tg2576 mouse model of AD.
Methods
First, we assessed expression levels of key proteins in the glutamate-glutamine cycle in Tg2576 ( n = 7) and wild-type littermates ( n = 7), and subsequently in the kindling model of epilepsy ( n = 6) and sham ( n = 6). Then, kindling susceptibility was assessed in three groups: 200 mg/kg ceftriaxone-treated Tg2576 (Tg-Ceft, n = 9); saline-treated Tg2576 (Tg-Sal, n = 9); and saline-treated wild-type (WT-Sal, n = 15). Mice were treated for seven days before kindling, and seizure susceptibility compared between groups.
Results
Protein levels of GLT-1 ( p = 0.0093) and glutamine synthetase ( p = 0.0016) were reduced in cortex of Tg2576 mice, compared to WT. Kindling increased GLT-1 (cortex: p < 0.0001, hippocampus: p = 0.0075), and glutaminase (cortex: p = 0.0044) protein levels, compared to sham. Both Tg-Ceft and WT-Sal displayed Class IV seizures in response to the first stimulation ( p > 0.99), while Tg-Sal displayed Class V seizure ( p = 0.0212 versus WT-Sal). Seizure susceptibility of Tg-Ceft was not different from Tg-Sal ( p > 0.05), and kindling rates did not differ between groups.
Conclusions
Disruptions to key components of the glutamate-glutamine cycle are observed in models of AD and epilepsy. However, increasing GLT-1 through ceftriaxone treatment did not influence seizure susceptibility in Tg2576 mice, suggesting this is not an effective strategy to lower seizure susceptibility in AD, or a higher dosage is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, School of Translational Medicine, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia.
- Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
- Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Parkville, Victoria, Australia.
- Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Hattapark Dejakaisaya, Nigel C Jones
Zitieren
APA
Dejakaisaya, H., Lin, R., Harutyunyan, A., Chan, J., Kwan, P., & Jones, N. C. (2024). Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877241289053
Vancouver
Dejakaisaya H, Lin R, Harutyunyan A, Chan J, Kwan P, Jones NC. Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease. Journal of Alzheimer’s Disease. 2024. doi:10.1177/13872877241289053
BibTeX
@article{Dejakaisaya2024,
author = {Dejakaisaya, Hattapark and Lin, Runxuan and Harutyunyan, Anna and Chan, Jianxiong and Kwan, Patrick and Jones, Nigel C},
title = {Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.1177/13872877241289053}
}
EUVIMED